{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:06:07Z","timestamp":1780567567682,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Currently, radiation therapy treatment planning system intends biological optimization that relies heavily upon plan metrics from tumor control probability (TCP) and normal tissue complication probability (NTCP) modeling. Implementation and expansion of TCP and NTCP models with alternative data is an important step towards reliable radiobiological treatment planning. In this retrospective single institution study, the treatment charts of 139 lung cancer patients treated with chemo-radiotherapy were reviewed and correlated dosimetric predictors with the incidence of esophagitis and established NTCP model of esophagitis grade 1 and 2 for lung cancer patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Esophagus is an organ at risk (OAR) in lung cancer radiotherapy (RT). Esophagitis is a common toxicity induced by RT. In this study, dose volume parameters V<jats:sub>x<\/jats:sub> (V<jats:sub>x<\/jats:sub>: percentage esophageal volume receiving\u2009\u2265\u2009x Gy) and mean esophagus dose (MED) as quantitative dose-volume metrics, the esophagitis grade 1 and 2 as endpoints, were reviewed and derived from the treatment planning system and the electronic medical record system. Statistical analysis of binary logistic regression and probit were performed to have correlated the probability of grade 1 and 2 esophagitis to MED and V<jats:sub>x<\/jats:sub>. IBM SPSS software version 24 at 5% significant level (\u03b1\u2009=\u20090.05) was used in the statistical analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The probabilities of incidence of grade 1 and 2 esophagitis proportionally increased with increasing the values of V<jats:sub>x<\/jats:sub> and MED. V<jats:sub>20<\/jats:sub>, V<jats:sub>30<\/jats:sub>, V<jats:sub>40<\/jats:sub>, V<jats:sub>50<\/jats:sub> and MED are statistically significant good dosimetric predictors of esophagitis grade 1. 50% incidence probability (TD<jats:sub>50<\/jats:sub>) of MED for grade 1 and 2 esophagitis were determined. Lyman Kutcher Burman model parameters, such as, n, m and TD<jats:sub>50<\/jats:sub>, were fitted and compared with other published findings. Furthermore, the sigmoid shaped dose responding curve between probability of esophagitis grade 1 and MED were generated respecting to races, gender, age and smoking status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>V<jats:sub>20<\/jats:sub>, V<jats:sub>30<\/jats:sub>, V<jats:sub>40<\/jats:sub> and V<jats:sub>50<\/jats:sub> were added onto Quantitative Analysis of Normal Tissue Effects in the clinic, or QUANTEC group\u2019s dose constrains of V<jats:sub>35<\/jats:sub>, V<jats:sub>50<\/jats:sub>, V<jats:sub>70<\/jats:sub> and MED. Our findings may be useful as both validation of 3-Dimensional planning era models and also additional clinical guidelines in treatment planning and plan evaluation using radiobiology optimization.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-023-02667-2","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T08:10:18Z","timestamp":1696839018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Model development of dose and volume predictors for esophagitis induced during chemoradiotherapy for lung cancer as a step towards radiobiological treatment planning"],"prefix":"10.1186","volume":"23","author":[{"given":"Rui","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William N.","family":"Duggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Chunli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Vijayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"2667_CR1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.ijrobp.2005.04.004","volume":"62","author":"K Takeda","year":"2005","unstructured":"Takeda K, Nemot K, Saito H, et al. Dosimetric correlation of acute esophagitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:626\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.04.004.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2667_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0360-3016(91)90171-y","volume":"1","author":"B Emami","year":"2013","unstructured":"Emami B. Tolerance of normal tissue to therapeutic radiation. Rep radiother oncol. 2013;1:35\u201348. https:\/\/doi.org\/10.1016\/0360-3016(91)90171-y.","journal-title":"Rep radiother oncol"},{"key":"2667_CR3","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ijrobp.2008.04.064","volume":"73","author":"N Rodriguez","year":"2009","unstructured":"Rodriguez N, Algara M, Foro P, et al. Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys. 2009;73:810\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.04.064.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"2667_CR4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","volume":"76","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM, Constine LS, Deasu JO, et al. Quantitative analyses of normal tissue effects in the clinic (QUANTEC): An introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S3\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.09.040.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2667_CR5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.ijrobp.2003.09.080","volume":"58","author":"J Bradley","year":"2004","unstructured":"Bradley J, Deasy JO, Bentzen S, et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:1106\u201313. https:\/\/doi.org\/10.1016\/j.ijrobp.2003.09.080.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2667_CR6","volume-title":"The use and QA of Biologically related Models for Treatment Planning, Report of AAPM Task Group 166","author":"XA Li","year":"2012","unstructured":"Li XA, Alber M, Deasy JO, et al. The use and QA of Biologically related Models for Treatment Planning, Report of AAPM Task Group 166. 2012."},{"issue":"3 Suppl","key":"2667_CR7","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability (NTCP) models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S10\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.07.1754.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2667_CR8","unstructured":"White paper from RaySearch Laboratories \u201cRadiobiological evaluation and optimization of treatment plans with RayBiology.\u201d Copyright 2007. \u00a9 RaySearch Laboratories AB, P.O. Box 3297, SE-103 65 Stockholm, Sweden. https:\/\/www.raysearchlabs.com\/siteassets\/about-overview\/media-center\/wp-re-ev-n-pdfs\/white-papers\/biological-optimization-and-evaluation-in-raystation2.pdf."},{"key":"2667_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-z","volume":"21","author":"C Burman","year":"1991","unstructured":"Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21:123\u201335. https:\/\/doi.org\/10.1016\/0360-3016(91)90172-z.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"2667_CR10","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.ijrobp.2009.05.070","volume":"76","author":"M Werner-Wasik","year":"2010","unstructured":"Werner-Wasik M, Yorke E, Deasy J, et al. Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S86\u201393. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.05.070.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2667_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.radonc.2005.10.001","volume":"77","author":"O Chapet","year":"2005","unstructured":"Chapet O, Kong F-M, Lee JS, et al. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol. 2005;77:176\u201381. https:\/\/doi.org\/10.1016\/j.radonc.2005.10.001.","journal-title":"Radiother Oncol"},{"key":"2667_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.radonc.2005.03.021","volume":"75","author":"J Belderbos","year":"2005","unstructured":"Belderbos J, Heemsbergen W, Hoogeman M, et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol. 2005;75:157\u201364. https:\/\/doi.org\/10.1016\/j.radonc.2005.03.021.","journal-title":"Radiother Oncol"},{"key":"2667_CR13","doi-asserted-by":"publisher","unstructured":"RTOG 1106\/ACRIN 6697, Randomized phase II trial of individualized adaptive radiotherapy using during-treatment FDG-PET\/CT and modern technology in locally advanced non-small cell lung cancer (NSCLC) https:\/\/www.nrgoncology.org\/Clinical-Trials\/Protocol\/rtog-1106?filter=rtog-1106817. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.04.064","DOI":"10.1016\/j.ijrobp.2008.04.064"},{"issue":"3 Suppl","key":"2667_CR14","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/j.ijrobp.2009.06.091","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Bentzen SM, Deasy JO, et al. Radiation dose volume effects in the lung. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S70\u20136. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.06.091.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2667_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.prro.2017.07.010","volume":"8","author":"P Paximadis","year":"2018","unstructured":"Paximadis P, Schipper M, Matuszak M, et al. Dosimetric predictors for acute esophagitis during radiation therapy for lung cancer: results of a large statewide observational study. Pract Radiat Oncol. 2018;8:167\u201373. https:\/\/doi.org\/10.1016\/j.prro.2017.07.010.","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"2667_CR16","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.3747\/co.23.2771","volume":"23","author":"L Jin","year":"2016","unstructured":"Jin L, Wang R, Jiang S, et al. 2016 \u201cDosimetric and clinical toxicity comparison of critical organ preservation with three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and RapidArc for the treatment of locally advanced cancer of the pancreatic head.\u201d Curr Oncol. 2016;23(1):e41\u20138. https:\/\/doi.org\/10.3747\/co.23.2771.","journal-title":"Curr Oncol"},{"key":"2667_CR17","doi-asserted-by":"publisher","first-page":"S1525","DOI":"10.1016\/j.cllc.2015.07.006","volume":"15","author":"DC Ling","year":"2015","unstructured":"Ling DC, et al. \u201cComparison of toxicity between intensity-modulated radiotherapy and 3-Dimensional conformal radiotherapy for locally advanced non-small-cell lung cancer\u201d Clin. Lung Cancer. 2015;15:S1525\u20137304. https:\/\/doi.org\/10.1016\/j.cllc.2015.07.006.","journal-title":"Lung Cancer"},{"issue":"1","key":"2667_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1118\/1.598063","volume":"24","author":"A Niemierko","year":"1997","unstructured":"Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 1997;24(1):103\u201310. https:\/\/doi.org\/10.1118\/1.598063.","journal-title":"Med Phys"},{"key":"2667_CR19","unstructured":"Bentzen S, Supersize it: Big data comes to radiation oncology research. ASTROnews, fall 2016;14. ASTROnews Annual Meeting Guide 2016- American Society for Radiation Oncology (ASTRO) - American Society for Radiation Oncology (ASTRO) https:\/\/www.astro.org\/News-and-Publications\/ASTROnews\/2016\/ASTROnews-2016-Annual-Meeting-Guide"},{"key":"2667_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.semradonc.2004.06.003","volume":"14","author":"J Bradley","year":"2004","unstructured":"Bradley J, Movsas B. Radiation esophagitis: predictive factors and preventive strategies. Semin Radiat Oncol. 2004;14:280\u20136. https:\/\/doi.org\/10.1016\/j.semradonc.2004.06.003.","journal-title":"Semin Radiat Oncol"},{"key":"2667_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ijrobp.2006.09.054","volume":"67","author":"EMT Dieleman","year":"2007","unstructured":"Dieleman EMT, et al. Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. Int J Radiat Oncol Biol Phys. 2007;67:775\u201380.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2667_CR22","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ijrobp.2004.10.042","volume":"62","author":"D Kahn","year":"2005","unstructured":"Kahn D, et al. Anatomically correct dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics. Int J Radiat Oncol Biol Phys. 2005;62:645\u201351. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.10.042.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02667-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02667-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02667-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T02:04:32Z","timestamp":1700359472000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02667-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2667"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02667-2","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"assertion":[{"value":"18 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study approved by IRB of University of Mississippi Medical Center, Jackson, MS, USA. The study approved is 2017\u20130023. All methods in this study were performed in accordance with the relevant guidelines and regulations of this IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"379"}}